Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Total 13F shares
-
567,029,372
-
Share change
-
-14,400,110
-
Total reported value
-
$5,101,188,907
-
Put/Call ratio
-
127%
-
Price per share
-
$9.01
-
Number of holders
-
421
-
Value change
-
-$198,579,913
-
Number of buys
-
165
-
Number of sells
-
195
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q3 2020
As of 30 Sep 2020,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) was held by
421 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
567,029,372 shares.
The largest 10 holders included
Capital Research Global Investors, Capital World Investors, Berkshire Hathaway Inc, BlackRock Inc., ABRAMS CAPITAL MANAGEMENT, L.P., Capital International Investors, Migdal Insurance & Financial Holdings Ltd., STATE STREET CORP, Clal Insurance Enterprises Holdings Ltd, and MENORA MIVTACHIM HOLDINGS LTD..
This page lists
421
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.